Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2012
12/05/2012CN102302645B Oral liquid for treating hypertensive cardio-cerebrovascular syndrome
12/05/2012CN102274346B Medicament or health food composition for preventing hypertension and preparation method and purpose thereof
12/05/2012CN102274202B Daidzein nanocrystal immediate-release capsule and preparation process thereof
12/05/2012CN102258758B High-content liquid gingerols and preparation method thereof
12/05/2012CN102258552B Method for preparing angelica dahurica decoction pieces
12/05/2012CN102210672B Application of polyketide in preparation of angiogenesis inhibiting medicine
12/05/2012CN102204942B Method for extracting corylus heterophylla leaf flavone
12/05/2012CN102188627B Medicament for treating apoplexy
12/05/2012CN102133277B Red paeony root active constituent as well as preparation method and application thereof
12/05/2012CN102125599B Preparation method and application of astragalus root active ingredient
12/05/2012CN102086193B N-substituted alpha-amino acid derivatives and preparation method and application thereof
12/05/2012CN102078603B Medicine with action of treating cardiovascular and cerebrovascular diseases
12/05/2012CN102056609B Pharmaceutical combination
12/05/2012CN102028938B Medicament having effects of activating blood and dissolving stasis
12/05/2012CN101951898B Medical use of 3-(2,2,2-trimethylhydrazinium) propionate hydrogen fumarate and dihydrogen phosphate
12/05/2012CN101829209B Preparation method of fruit-flavored sweet tea polyphenols
12/05/2012CN101810768B Antithrombotic Chinese medicinal powder and preparation method thereof
12/05/2012CN101756988B Compound matrine and diversine nano-emulsion preparation and preparation method thereof
12/05/2012CN101654418B A type crystal of mildronate dihydrate and preparation method thereof
12/05/2012CN101623282B Aspirin-dipyridomole sustained-release capsule and preparation method thereof
12/05/2012CN101590095B Compound medicine containing gypenosides and folic acid compound
12/05/2012CN101590084B Pharmaceutical composition containing angiotensin converting enzyme inhibitors, B vitamins and ginkgo biloba extracts
12/05/2012CN101370486B Transdermal patch containing Isosorbide Dinitrate and bisoprolol
12/05/2012CN101356156B Aspartic protease inhibitors
12/05/2012CN101330919B Pharmaceutical composition including (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2- [methyl(methylsulfonyl)amino]pyrim idin-5-yl]-(3R, 5S)-3,5-dihydroxyhept-6-enoic acid
12/04/2012US8324386 Somatostatin-dopamine chimeric analogs
12/04/2012US8324267 Kinase inhibitors and the use thereof
12/04/2012US8324241 Triazolo compounds useful as DGAT1 inhibitors
12/04/2012US8324222 Cyclically substituted furopyrimidine derivatives and use thereof
12/04/2012US8324214 1,3-dihydro-2H-pyrrolo[3,2-bpyridin-2-one derivatives, preparation thereof and therapeutic uses thereof
12/04/2012US8324210 Pterin analogs
12/04/2012US8324205 Quinazoline derivatives as kinase inhibitors
12/04/2012US8324190 Treatment of proliferative disorders with amino-substituted (E)-2,6- dialkoxystyryl 4-substituted benzylsulfones
12/04/2012US8324178 Method of treatment using alpha-1-adrenergic agonist compounds
12/04/2012US8324176 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
12/04/2012US8324152 Composition for the treatment of atherosclerosis
12/04/2012CA2716874C A pharmaceutical composition and its use in the preparation of a medicament for the treatment of cerebrovascular diseases
12/04/2012CA2695973C Novel salt of isoquinoline compound and crystal thereof
12/04/2012CA2617363C Use of ivabradine for the manufacture of medications for the treatment of endothelial dysfunction
12/04/2012CA2575768C Method for screening toxin neutralizing peptide, stx2 inhibiting peptide and verotoxin neutralizing agent
12/04/2012CA2573479C Effective use method of medicaments and method of preventing expression of side effect
12/04/2012CA2572743C Methods for improving bioavailability of a renin inhibitor
12/04/2012CA2557269C Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
12/04/2012CA2501282C Vasoregulating compounds and methods of their use
12/04/2012CA2474798C Method and composition for treatment of inflammation and aids-associated neurological disorders
12/04/2012CA2463879C Glycoprotein compositions
12/04/2012CA2222509C Connective tissue growth factor
11/2012
11/29/2012WO2012162531A1 Inhibitors of galectin-3 and methods of use thereof
11/29/2012WO2012162463A1 Benzothiazolyl inhibitors of pro-matrix metalloproteinase activation
11/29/2012WO2012162461A1 Phenyl-thiazolyl inhibitors of pro-matrix metalloproteinase activation
11/29/2012WO2012162394A2 Compositions and methods for treating renal disease
11/29/2012WO2012162392A1 Endothelium protective materials and methods of use
11/29/2012WO2012161622A2 Incretin hormone secretion stimulators, method for producing and using same
11/29/2012WO2012161173A1 Substituted amide compound
11/29/2012WO2012160034A1 4-aryl-n-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
11/29/2012WO2012159557A1 Substituted triazine phenylurea derivative and use thereof against tumors
11/29/2012WO2012159552A1 Solid pharmaceutical composition containing benzimidazole derivative
11/29/2012WO2012159511A1 Azilsartan solid dispersion, preparation method and pharmaceutical compositions thereof
11/29/2012WO2012159456A1 Cdc42 inhibitor and uses thereof
11/29/2012WO2012159215A1 Compositions and methods for efficacious and safe delivery of sirna using specific chitosan-based nanocomplexes
11/29/2012WO2012138147A3 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid crystalline form and the producing method thereof
11/29/2012WO2012138043A3 Therapeutic composition containing endothelin as an active component
11/29/2012WO2011140682A8 (2e)-3-phenyl-n-[2,2,2-trifluoro-1-[[(8-quinolineamino)thiomethyl]amino]ethyl]-2-acrylamide and pharmaceutical uses thereof
11/29/2012US20120303083 Novel desmin phosphorylation sites useful in diagnosis and intervention of cardiac disease
11/29/2012US20120302639 Omega 3 formulations for treatment of risk factors for cardiovascular disease and protection against sudden death
11/29/2012US20120302637 Methods of Treating Tachycardia and/or Controlling Heart Rate While Minimizing and/or Controlling Hypotension
11/29/2012US20120302636 Method of treating a disorder associated with mtp
11/29/2012US20120302632 Dietary control of arachidonic acid metabolism
11/29/2012US20120302630 Na/K-ATPase Ligands, Ouabain Antagonists, Assays and Uses Thereof
11/29/2012US20120302620 Novel pyrone-indole derivatives and process for their preparation
11/29/2012US20120302607 C4-substituted alpha-keto oxazoles
11/29/2012US20120302604 Modulation of Phospholipase D for the Treatment of the Acute and Chronic Effects of Ethanol
11/29/2012US20120302602 Vanilloid Receptor Ligand Compounds, Pharmaceutical Compositions Containing Them, a Method of Producing Them and the Use Thereof to Treat Pain and Various Other Conditions
11/29/2012US20120302599 KAT ll INHIBITORS
11/29/2012US20120302591 Methods of using 8-carboxamido-2,6-methano-3-benzazocines
11/29/2012US20120302587 Rho-kinase inhibitors
11/29/2012US20120302585 Inhibitors of fatty acid uptake and methods of use
11/29/2012US20120302584 Novel salts forms of pyrimidin-5-yl acetic acid derivative
11/29/2012US20120302583 New Compounds I
11/29/2012US20120302578 Aminooxazole Inhibitors of Cyclin Dependent Kinases
11/29/2012US20120302575 Methods for Preventing Oxidative Stress Injury of a Tissue by a Folate-Tempol Conjugate.
11/29/2012US20120302573 Methods of inhibiting pro matrix metalloproteinase activation
11/29/2012US20120302569 Phenyl-thiazolyl inhibitors of pro-matrix metalloproteinase activation
11/29/2012US20120302566 Indanyloxydihydrobenzofuranylacetic acids
11/29/2012US20120302557 Biologically active methylene blue derivatives
11/29/2012US20120302555 Method of treatment using eprosartan
11/29/2012US20120302544 Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators
11/29/2012US20120302541 4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators
11/29/2012US20120302539 Transglutaminase tg2 inhibitors, pharmaceutical compositions, and methods of use thereof
11/29/2012US20120302537 Treatment methods using pharmaceutical solid state forms
11/29/2012US20120302505 Cyclodextrin-based polymers for therapeutic delivery
11/29/2012US20120302504 Method Of Reducing Injury To Mammalian Cells
11/29/2012US20120302501 Treatment of diabetic cardiomyopathy with a glp-1 peptide
11/29/2012US20120302498 Insulin like peptides
11/29/2012US20120302493 Cyclic Peptides As G-Protein Coupled Receptor Antagonists
11/29/2012US20120302491 Modulation of estrogen receptor-related receptor gamma (err gamma) and uses therefor
11/29/2012US20120301549 Complex formulation comprising aspirin coated with barrier containing hydrophobic additive, and hmg-coa reductase inhibitor
11/29/2012US20120301538 Pharmaceutical compositions for the stimulation of stem cells
11/29/2012US20120301491 Use of Modified Extracellular Matrix Proteins in Diagnosis and Treatment of Atherosclerosis
11/29/2012US20120301483 Complement pathway inhibitors binding to c5 and c5a without preventing the formation of c
1 ... 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 ... 1595